Taiwan Time | Topic | Speaker | Moderator |
---|---|---|---|
8:30-8:35 | Opening Remarks: Suporn Treepongkaruna (President of APPSPGHAN) | ||
8:35-8:40 | Welcome Message: Huey-Ling Chen (President of TSPGHAN) | ||
Impact of Covid-19 on Hepatology Practice | |||
8:40-9:00 | Special Lecture Impact of Covid-19 on Pediatric Liver Transplantation |
Mercedes Martinez (USA) |
Suporn Treepongkaruna (President of APPSPGHAN) |
9:00-9:10 | Discussion
Suporn Treepongkaruna
(President of APPSPGHAN) |
||
9:10-10:40 | Cholestatic and Metabolic Liver Diseases | ||
9:10-9:30 | Novel Treatment in Cholestatic Diseases (IBAT Inhibitor Trials) | Saul J. Karpen (USA) |
Huey-Ling Chen (President of TSPGHAN) Kazuhiko Bessho (Japan) |
9:30-9:50 | Bile Acid Metabolic Disorders in Asia-Pacific Region-the Importance of Early Diagnosis | Tatsuki Mizuochi (Japan)
Huey-Ling Chen
(President of TSPGHAN) Kazuhiko Bessho (Japan) |
|
9:50-10:20 | Keynote Lecture Recent Advances in the Diagnosis and Prognosis Prediction of Biliary Atresia and Cholestatic Liver Diseases |
Jorge A Bezerra (USA)
Huey-Ling Chen
(President of TSPGHAN) Kazuhiko Bessho (Japan) |
|
10:20-10:40 | Discussion
Huey-Ling Chen
(President of TSPGHAN) Kazuhiko Bessho (Japan) |
||
10:40-12:20 | NAFLD and Gut Liver Axis | ||
10:40-11:00 | Therapeutic Updates of Pediatric NAFLD | Stavra Xanthakos (USA) |
Way Seah Lee (Malaysia) Chun Yan Yeung (Taiwan) |
11:00-11:20 | NAFLD from Asian Perspectives | Yu-Cheng Lin (Taiwan)
Way Seah Lee
(Malaysia) Chun Yan Yeung (Taiwan) |
|
11:20-11:40 | Assessment of Pediatric NAFLD | Voranush Chongsrisawat (Thailand)
Way Seah Lee
(Malaysia) Chun Yan Yeung (Taiwan) |
|
11:40-12:00 | Microbiome, Fatty Liver, and Pediatric Health | Yen-Hsuan Ni (Taiwan)
Way Seah Lee
(Malaysia) Chun Yan Yeung (Taiwan) |
|
12:00-12:20 | Discussion
Way Seah Lee
(Malaysia) Chun Yan Yeung (Taiwan) |
Taiwan Time | Topic | Speaker | Moderator |
---|---|---|---|
12:20-13:50 | Viral Hepatitis: Toward Global Elimination of Hepatitis | ||
12:20-12:50 | Keynote Lecture The Impact of Neonatal Immunization and Maternal Antiviral Treatment on Mother-to-Infant Transmission of HBV Infection |
Mei-Hwei Chang (Taiwan) |
Winita Hardikar (Australia) Yao-Jong Yang (Taiwan) |
12:50-13:10 | Updates of HBV Treatment in Children | Ayano Inui (Japan)
Winita Hardikar
(Australia) Yao-Jong Yang (Taiwan) |
|
13:10-13:30 | A Practical Guide to Treating Paediatric HCV in the Asia-Pacific Region Now | Winita Hardikar (Australia)
Winita Hardikar
(Australia) Yao-Jong Yang (Taiwan) |
|
13:30-13:50 | Discussion
Winita Hardikar
(Australia) Yao-Jong Yang (Taiwan) |
||
13:50-15:10 | Advances in Pediatric Liver Disease Management | ||
13:50-14:10 | Wilson Disease: Updates in Diagnosis, Treatment, and Disease Monitoring | Jae Sung Ko (Korea) |
Jae Sung Ko (Korea) Jia-Feng Wu (Taiwan) |
14:10-14:30 | Liver Transplantation in Babies Below 5 kg | Anupam Sibal (India)
Jae Sung Ko
(Korea) Jia-Feng Wu (Taiwan) |
|
14:30-14:50 | Long-Term Follow-up of FIC1 and BSEP Deficiency Patients-the NAPPED Consortium | Henkjan J Verkade (Netherland)
Jae Sung Ko
(Korea) Jia-Feng Wu (Taiwan) |
|
14:50-15:10 | Discussion
Jae Sung Ko
(Korea) Jia-Feng Wu (Taiwan) |
||
15:10 |
Closing Remarks:
Suporn Treepongkaruna (President of APPSPGHAN)
Huey-Ling Chen (President of TSPGHAN) |